EDE and Novo Nordisk MoU: Strengthening UAE Pharmaceutical Ecosystem and Supply Chain - News and Statistics

Jun 8, 2026

The Emirates Drug Establishment (EDE) has entered into a memorandum of understanding with Novo Nordisk, a global healthcare company recognized for its work in diabetes, obesity, and rare disease treatments, according to a statement reported by TradeArabia News Service.

The agreement focuses on strengthening cooperation in pharmaceutical manufacturing through advanced technologies. It also aims to support the creation of an innovative and sustainable pharmaceutical ecosystem within the UAE.

Under the MoU, the two parties will enhance collaboration on supply chain security by increasing in-country value and expanding partnerships that help ensure the continuity of pharmaceutical supplies. The statement indicated that the memorandum is expected to bolster the resilience of the healthcare sector and contribute to the sustainable availability of medicines across the country.

The partnership includes talent development and capacity-building programs designed to strengthen national capabilities. These initiatives involve training, knowledge exchange, and professional development pathways. Additionally, Emirati talent and students will gain opportunities to participate in academic, internship, and hands-on programs within the pharmaceutical sector.

In the areas of innovation, research, and development, the memorandum seeks to establish a supportive regulatory environment that accelerates the introduction of new therapies and expands access to them. It will also promote greater involvement by UAE-based institutions and stakeholders in product development and research projects related to Novo Nordisk’s activities.

The statement concluded that the partnership is expected to enhance the readiness and resilience of the UAE’s pharmaceutical sector, strengthen the sustainability of its ecosystem, expand opportunities for innovation and development, and reinforce the country’s position among leading hubs for advanced pharmaceutical industries in the region and globally.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

REPORT DESCRIPTION
RESEARCH METHODOLOGY AND THE AI PLATFORM
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
GLOSSARY AND SPECIFIC TERMS

2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

KEY FINDINGS
MARKET TRENDS This Chapter is Available Only for the Professional EditionPRO

3. MARKET OVERVIEW

Understanding the Current State of The Market and its Prospects

MARKET SIZE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
CONSUMPTION BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
MARKET FORECAST TO 2035

4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION

Finding New Products to Diversify Your Business

TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
BEST-SELLING PRODUCTS
MOST CONSUMED PRODUCTS
MOST TRADED PRODUCTS
MOST PROFITABLE PRODUCTS FOR EXPORT

5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

TOP COUNTRIES TO SOURCE YOUR PRODUCT
TOP PRODUCING COUNTRIES
TOP EXPORTING COUNTRIES
LOW-COST EXPORTING COUNTRIES

6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Export

TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
TOP CONSUMING MARKETS
UNSATURATED MARKETS
TOP IMPORTING MARKETS
MOST PROFITABLE MARKETS

7. PRODUCTION

The Latest Trends and Insights into The Industry

PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
PRODUCTION BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)

8. IMPORTS

The Largest Import Supplying Countries

IMPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)

9. EXPORTS

The Largest Destinations for Exports

EXPORTS: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)
EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2025) AND FORECAST (2026–2035)

10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

11. COUNTRY PROFILES

The Largest Markets And Their Profiles

This Chapter is Available Only for the Professional Edition
PRO

11.1

United States